LivaNova PLC
NASDAQ:LIVN

Watchlist Manager
LivaNova PLC Logo
LivaNova PLC
NASDAQ:LIVN
Watchlist
Price: 51.32 USD -0.74% Market Closed
Market Cap: 2.8B USD
Have any thoughts about
LivaNova PLC?
Write Note

LivaNova PLC
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

LivaNova PLC
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
LivaNova PLC
NASDAQ:LIVN
PP&E Net
$220.9m
CAGR 3-Years
4%
CAGR 5-Years
-1%
CAGR 10-Years
18%
Smith & Nephew PLC
LSE:SN
PP&E Net
$1.4B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
N/A
EKF Diagnostics Holdings PLC
LSE:EKF
PP&E Net
ÂŁ24.9m
CAGR 3-Years
22%
CAGR 5-Years
14%
CAGR 10-Years
9%
Angle PLC
LSE:AGL
PP&E Net
ÂŁ6.7m
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Creo Medical Group PLC
LSE:CREO
PP&E Net
ÂŁ8.5m
CAGR 3-Years
39%
CAGR 5-Years
49%
CAGR 10-Years
N/A
B
Belluscura PLC
LSE:BELL
PP&E Net
$399.6k
CAGR 3-Years
1%
CAGR 5-Years
69%
CAGR 10-Years
N/A
No Stocks Found

LivaNova PLC
Glance View

Market Cap
2.8B USD
Industry
Health Care

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. The firm is focused on the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems throughout the world. The firm operates through two segments: Cardiac Surgery and Neuromodulation. Its Cardiac Surgery Business Franchise (CS) is engaged in the development, production and sale of cardiac surgery products, including oxygenators, heart-lung machines, perfusion tubing systems, cannulae and other accessories used for extracorporeal circulation, systems for autologous blood transfusion and blood washing. Its Neuromodulation Business Franchise designs develops and markets neuromodulation-based medical devices for the treatment of epilepsy and difficult-to-treat depression (DTD) and obstructive sleep apnea.

LIVN Intrinsic Value
81.64 USD
Undervaluation 37%
Intrinsic Value
Price

See Also

What is LivaNova PLC's PP&E Net?
PP&E Net
220.9m USD

Based on the financial report for Sep 30, 2024, LivaNova PLC's PP&E Net amounts to 220.9m USD.

What is LivaNova PLC's PP&E Net growth rate?
PP&E Net CAGR 10Y
18%

Over the last year, the PP&E Net growth was 22%. The average annual PP&E Net growth rates for LivaNova PLC have been 4% over the past three years , -1% over the past five years , and 18% over the past ten years .

Back to Top